Devices › Device types
FDA product code MEB · class 2 · General Hospital
Pump, infusion, elastomeric: medical device reports filed with FDA
33,522 reports carry this product code, 1993–2026; 30 brands with a page.
- 33,522
- reports with this product code
- 0.1% of all MAUDE reports
- 1,385
- reports, 12 months to August 2026
- 1,397 in the 12 months before
- 90.4%
- classified as malfunction
- 62.3% across all reports
- 0.2%
- classified as death, as reported
- 0.9% across all reports
Product code MEB is FDA's classification for "Pump, infusion, elastomeric" (general Hospital panel), a class 2 device. 33,522 medical device reports carry this product code, 0.1% of the MAUDE database, from November 1993 to August 2026.
1,385 reports arrived in the 12 months to August 2026, close to the 1,397 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (90.4%), injury (5.9%) and other (3.2%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Infusor | 14,804 | 620 | 0% | 99.5% |
| FOLFusor | 7,404 | 525 | 0% | 99.5% |
| Easypump | 730 | 90 | 0.1% | 81.8% |
| On-Q Painbuster | 314 | 0 | 0.6% | 4.3% |
| On-Q Pain Pump | 259 | 0 | 0% | 2.3% |
| On-Q Pump | 226 | 0 | 0.9% | 5.3% |
| Eclipse Homepump | 193 | 0 | 0% | 97.8% |
| Ce Infusor Lv 5 12 Pack | 192 | 0 | 0% | 99% |
| Easypump 2 | 165 | 14 | 0% | 100% |
| Intermate | 126 | 47 | 0% | 99.9% |
| On-Q Silversoaker | 118 | 0 | 0.7% | 4% |
| Stryker | 70 | 5 | 1.3% | 46.3% |
| Ce Intermate Lv 100 24 Pack 50126 | 59 | 0 | 0% | 99.4% |
| Ce Intermate Lv 250 24 Pack 50126 | 46 | 0 | 0% | 98.7% |
| Eclipse | 19 | 44 | 0.7% | 82.2% |
| Unknown Catheter | 14 | 26 | 2.2% | 38.1% |
| Avanos | 8 | 38 | 1.2% | 91.2% |
| Donjoy | 6 | 3 | 0% | 68.9% |
| Flogard | 5 | 0 | 0% | 99.9% |
| Infusomat Space | 5 | 12 | 0.2% | 96.1% |
| Catheter | 4 | 9 | 3.7% | 27.9% |
| Asku | 3 | 210 | 1.1% | 47.1% |
| Infuso R Pump | 3 | 0 | 0% | 99.2% |
| Walkmed | 3 | 0 | 0% | 95.8% |
| Infusomat Space - Us Version | 2 | 0 | 0.2% | 92.4% |
| Cadd Ms3 Pump | 1 | 0 | 0% | 93.7% |
| Clearlink Continu-Flo Solution Set | 1 | 6 | 0.1% | 98.6% |
| Infusion Pump | 1 | 6 | 3.7% | 46.1% |
| Novum IQ | 1 | 809 | 0.2% | 91.2% |
| Synchromed | 1 | 3 | 3.2% | 35.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Baxter Healthcare - Irvine | 14,691 | 43.8% |
| Baxter Healthcare | 10,017 | 29.9% |
| I-Flow | 2,442 | 7.3% |
| B Braun Melsungen | 1,613 | 4.8% |
| Avanos Medical | 547 | 1.6% |
| Stryker Instruments Kalamazoo | 221 | 0.7% |
| Stryker Instruments | 125 | 0.4% |
| Stryker | 52 | 0.2% |
| Halyard Health | 33 | 0.1% |
| B Braun Medical | 29 | 0.1% |
| Kimberly-Clark | 28 | 0.1% |
| Alaris Medical Systems | 23 | 0.1% |
| Moog Medical Devices Group | 20 | 0.1% |
| Hospira | 4 | 0% |
| Baxter Healthcare - Singapore | 3 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Fluid/blood leak | 6,560 | 19.6% |
| Filling problem | 4,794 | 14.3% |
| Material rupture | 3,748 | 11.2% |
| No flow | 3,154 | 9.4% |
| Excess flow or over-infusion | 2,499 | 7.5% |
| Device contamination with chemical or other material | 1,886 | 5.6% |
| Leak/splashthe device leaked | 1,576 | 4.7% |
| Infusion or flow problema problem with flow or infusion | 1,250 | 3.7% |
| Insufficient device problem information | 1,172 | 3.5% |
| Breakthe device broke | 979 | 2.9% |
| Insufficient flow or under infusion | 928 | 2.8% |
| Inaccurate flow rate | 680 | 2% |
| Failure to infuse | 637 | 1.9% |
| Failure to deliverthe device did not deliver the dose or item | 524 | 1.6% |
| Detachment of device component | 346 | 1% |
| Disconnection | 315 | 0.9% |
| Device operates differently than expectedthe device behaved unexpectedly | 298 | 0.9% |
| Crackthe device cracked | 258 | 0.8% |
| Component missing | 251 | 0.7% |
| Improper flow or infusion | 231 | 0.7% |
Questions about pump, infusion, elastomeric reports
What is product code MEB?
FDA's classification code for "Pump, infusion, elastomeric", class 2, reviewed by the general Hospital panel. Every device report carries the product code of the device involved.
How many reports carry this code?
33,522 reports through August 2026, 1,385 of them in the latest 12 months.
Which brands appear most often?
Infusor (14,804), FOLFusor (7,404), Easypump (730), On-Q Painbuster (314) and On-Q Pain Pump (259). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.